Original Research
Published on 15 Sep 2022
CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma
in Thoracic Oncology
![CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma](https://www.frontiersin.org/files/myhome article library/865756/865756_Thumb_400.jpg)
- 2,104 views
- 5 citations
Original Research
Published on 15 Sep 2022
in Thoracic Oncology
Original Research
Published on 15 Sep 2022
in Thoracic Oncology
Original Research
Published on 14 Sep 2022
in Thoracic Oncology
Original Research
Published on 14 Sep 2022
in Thoracic Oncology
Original Research
Published on 14 Sep 2022
in Thoracic Oncology
Original Research
Published on 14 Sep 2022
in Thoracic Oncology
Original Research
Published on 14 Sep 2022
in Thoracic Oncology
Case Report
Published on 14 Sep 2022
in Thoracic Oncology
Original Research
Published on 14 Sep 2022
in Thoracic Oncology
Brief Research Report
Published on 13 Sep 2022
in Thoracic Oncology
Original Research
Published on 13 Sep 2022
in Thoracic Oncology
Original Research
Published on 09 Sep 2022
in Thoracic Oncology
Case Report
Published on 08 Sep 2022
in Thoracic Oncology
Brief Research Report
Published on 07 Sep 2022
in Thoracic Oncology
Original Research
Published on 05 Sep 2022
in Thoracic Oncology
Case Report
Published on 05 Sep 2022
in Thoracic Oncology